Fischer Medical Ventures Limited has announced the conversion of 60,00,000 convertible warrants into equity shares, resulting in an infusion of Rs 10.53 crore from the promoter category.

The disclosure was made through a Regulation 30 filing with stock exchanges on March 31, 2026. 

The company’s Board, through a circular resolution passed on Tuesday, approved the allotment of 60 lakh fully paid-up equity shares with a face value of Re 1 each at an issue price of Rs 23.40 per share, including a premium of Rs 22.40 per share. The shares were issued upon exercise of warrants previously allotted to the promoter shareholder. 

According to the filing, the company received the remaining 75 percent exercise amount of Rs 17.55 per warrant, aggregating Rs 10,53,00,000, before completing the conversion. The entire allotment has been made to Shankar Varadharajan, promoter, who converted all 60 lakh warrants into an equivalent number of equity shares. 

This conversion is expected to further strengthen promoter holding in Fischer Medical Ventures Limited while also augmenting the company’s capital base to support its strategic growth plans in the medical ventures segment.